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cardiographic evaluation showed that deceleration time 
(237.57 ± 40.10 ms;  p = 0.030), isovolumic relaxation time 
(126.84 ± 15.62 ms;  p < 0.001), early (E)/late (A) ventricular 
filling velocity (E/A) ratio (1.15 ± 0.40;  p  ≤ 0.001), and aortic 
stiffness index value (9.62 ± 4.53;  p = 0.016) exhibited a sta-
tistical increase in hemodialysis patients with fQRS com-
pared to patients without fQRS. E (58.23 ± 19.96 m/s;  p = 
0.004), and Em (5.96 ± 2.08 cm/s;  p = 0.023) velocity levels 
were significantly lower in hemodialysis patients with fQRS 
than patients without fQRS. Aortic stiffness closely correlat-
ed with diastolic dysfunction (deceleration time  r = 0.273,
 p = 0.042; isovolumic relaxation time  r = 0.497,  p < 0.001; E/A 
ratio  r = –0.449,  p = 0.001). On multivariate linear regression 
analysis, fQRS and aortic stiffness were independently asso-
ciated in hemodialysis patients (β = 0.321,  p = 0.049).  Conclu-
sions: Increased aortic stiffness and left ventricular systolic 
dysfunction were observed more frequently in hemodialysis 
patients with fQRS than in patients without fQRS. fQRS is an 
important determinant of aortic stiffness in hemodialysis pa-
tients.  © 2016 S. Karger AG, Basel 
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 Abstract 
 Objective: This study aimed to evaluate the correlation be-
tween fragmented QRS complex (fQRS), aortic stiffness, and 
diastolic dysfunction in hemodialysis patients.  Subjects and 
Methods: A sample of 56 patients who received hemodialy-
sis treatment was stratified into 2 groups according to their 
electrocardiography (ECG) patterns with or without fQRS. 
Baseline characteristics and laboratory parameters of pa-
tients were documented. Conventional echocardiographic 
and Doppler echocardiographic procedures were performed 
in all patients. The mean early (Em) diastolic and late (Am) 
diastolic myocardial velocities were calculated. These tests 
were performed before dialysis. The Student  t test, Mann-
Whitney U test, χ 2 test, Spearman correlation, and multivari-
ate linear regression analysis were used to analyze parame-
ters where appropriate.  Results: Of the 56 patients under 
hemodialysis, fQRS in ECG was detected in 26 (46.4%). Echo-
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 Chronic kidney disease (CKD) is an independent risk 
factor for cardiovascular disease and is associated with 
increased cardiovascular morbidity and mortality  [1] . 
Identification of patients at risk could alert physicians to 
monitor cardiovascular risk and implement the control 
of the aggressive risk factors. 
 A fragmented QRS complex (fQRS) is a bunch of elec-
trocardiographic signals that show ventricular conduc-
tion delays in scarred myocardial regions  [2] . The pres-
ence of fQRS complexes had been found to be associated 
with all-cause mortality and recurrent cardiac events  [3] . 
fQRS had been shown as a highly sensitive and specific 
marker of myocardial scar  [4] .
 Arterial stiffness is a measure of how the large arteries 
react to changes in blood pressure, and it is an important 
marker for endothelial dysfunction and atherosclerosis. 
Arterial stiffness increase is shown to be related with left 
ventricular (LV) diastolic dysfunction  [5] . Aortic stiffness 
and LV diastolic dysfunction basically share a common 
etiological mechanism that includes tissue fibrosis. Myo-
cardial fibrosis and scar result in deterioration of LV ac-
tivities. It had been shown that inhomogeneous LV activ-
ity is related to fQRS formation in electrocardiography 
 [6] . Korkmaz et al.  [6] had shown the relation between 
aortic stiffness and fQRS in asymptomatic hypertensive 
patients. Although fQRS is known to be associated with 
increased cardiovascular morbidity and mortality, its role 
in predicting subclinical heart damage and effects on dia-
stolic dysfunction and aortic stiffness has not been re-
ported previously in hemodialysis patients. Hence, this 
study aimed to evaluate the relation among fQRS, dia-
stolic dysfunction, and aortic stiffness in patients with 
CKD by using echocardiography and electrocardiogra-
phy (ECG).
 Materials and Methods 
 Patient Selection 
 Fifty-Six consecutive patients with CKD who had undergone 
hemodialysis treatment 3 times a week for at least 1 year in Ahi 
Evran University Medical Faculty from June 2014 to April 2015 
were recruited into this study. Exclusion criteria were active infec-
tions, bundle-branch block (left bundle-branch block, incomplete 
or complete right bundle-branch block) or intraventricular con-
duction delay (duration of QRS >120 ms) on ECG, permanent 
pacemakers, significant stenosis by fractional flow reserve mea-
surement, history of percutaneous or surgical revascularization, 
moderate to severe valve disease, LV dysfunction (ejection frac-
tion <40%), liver failure, atrial fibrillation, congenital heart dis-
ease, systemic conditions (ankylosing spondylitis, rheumatoid ar-
thritis, Marfan and Ehlers-Danlos disease), and aortic aneurysms. 
The 56 patients were stratified into 2 groups according to their 
ECG patterns with (group 1;  n = 26) or without fQRS (group 2;
 n  = 30). Systolic and diastolic blood pressures were measured in 
each individual twice, following a 5-min rest, with an Erka brand 
sphygmomanometer using an appropriate cuff width. Fifteen pa-
tients who were on hypertension medication were recorded. The 
protocol was approved by the institutional review boards of the 
Faculty of Medicine, Pamukkale University, Denizli, Turkey, and 
adhered to the Declaration of Helsinki. Patients were informed 
about the study, and written consent was obtained from all sub-
jects.
 Biochemical Analysis 
 A 5-mL blood sample was taken just before hemodialysis treat-
ment following 12 h of fasting. Complete blood count measure-
ment was made using flow cytometry, fasting blood glucose, cre-
atinine, albumin, and serum lipid measurements with an enzy-
matic colorimetric method, C-reactive protein measurements 
were done using an immunoturbidimetric method, and sodium, 
potassium, and chloride measurements were made with an ion-
selective electrode method. A Sysmex XT 2000I device was used 
for complete blood count, and the other biochemical parameters 
were studied using the Modular P Roche/Hitachi device. 
 Measurement of fQRS 
 fQRS was defined as presence of at least 1 of the following find-
ings in 12-lead routine ECG before dialysis: presence of an addi-
tional R wave (R’), notching of R or S wave, or >1 R’ fragmentation 
in 2 contiguous leads  [7] . The ECGs were analyzed by 2 indepen-
dent cardiologists (G.N., A.İ.) blinded to the patient characteris-
tics.
 Echocardiographic Data 
 Echocardiography was performed in the patients approximate-
ly 1 h before dialysis after a 15-min rest. The entire study popula-
tion of the 56 patients underwent screening by 2-dimensional 
echocardiography, which consisted of conventional Doppler so-
nography via a standard 2-dimensional transducer device (Ving-
med System Vivid 5; GE Vingmed Ultrasound, Horten, Norway); 
images were obtained in the left lateral decubitus position. LV fill-
ing was evaluated by pulse wave Doppler sonography, from the 
apical 4-chamber view, with the sample volume positioned at the 
tips of the mitral valve. We recorded the early (E)/late (A) ven-
tricular filling velocity (E/A) ratio, isovolumic relaxation time 
(IVRT), and E wave deceleration time (DT), together with early 
and late diastolic velocities. Tissue Doppler imaging utilizes mod-
ified wall filter and reduced gain in order to display myocardial 
velocity while avoiding blood flow detection. From the 4-chamber 
view, the tissue Doppler imaging sample volume was placed se-
quentially at septal and lateral sides of the valvular ring. The mean 
early (Em) diastolic, late diastolic, and systolic myocardial veloci-
ties were calculated (cm/s). Furthermore, we measured the
E/Em ratio. All measurements were done at 50 m/s at the end of 
the expiration. The modified Simpson method was used to calcu-
late LV ejection fraction. 
 The M-mode rod was placed so that it could pass through the 
aortic region that was 3 cm distal to the aortic valve. Systolic and 
diastolic diameters of the ascending aorta were obtained from the 
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aortic trace. Systolic diameter was measured from the location of 
the aortic trace in which the maximum forward movement was 
observed, while diastolic diameter was measured from the location 
that corresponded to the R spike of the ECG. To determine the 
pulse pressure, which was necessary for the calculation of relevant 
parameters, the systolic blood pressure and diastolic blood pres-
sure were concurrently measured with a mercury sphygmoma-
nometer. The difference between the 2 blood pressure values was 
accepted as the pulse pressure. Average systolic and diastolic mea-
surements were calculated following 3 consecutive measurements. 
The aortic elastic properties were calculated by using the formulae 
below:
12













aortic systolic diameter aortic diastolic diameter
 Statistical Analysis 
 The continuous variables are expressed as means ± SD, where-
as categorical variables are percentages.  p < 0.05 was statistically 
significant. Parametric continuous variables were compared by the 
independent Student  t test or Mann-Whitney U test. Categorical 
variables were analyzed by the χ 2 and Fisher exact tests. Spearman 
correlation was used for correlation analysis. Multiple regression 
analysis was made for the relation between fQRS and aortic stiff-
ness. The statistical analyses were carried out with the Windows 
SPSS v17.0 package program.
 Results 
 There were no significant differences between patients 
with fQRS and without fQRS when they were evaluated 
for baseline characteristics such as etiology of CKD, med-
ications, gender and age ( Table 1 ), and laboratory param-
eters ( p > 0.05;  Table 2 ).
 Echocardiographic evaluation showed that diastolic 
parameters like early diastolic velocity (58.23 ± 19.96 m/s; 
 p = 0.004), and Em (5.96 ± 2.08 cm/s;  p = 0.023) levels were 
significantly low in hemodialysis patients with fQRS. DT 
(237.57 ± 40.10 ms;  p = 0.030), IVRT ( p < 0.001), and E/A 
ratio (1.15 ± 0.40; p < 0.001) values exhibited a statistical 
 Table 1.  Comparison of biochemical features of the hemodialysis 
patients
Group 1 Group 2 p value
Leukocytes, n/mm3 7.61 ± 2.82 7.92 ± 3.51 0.764
Hemoglobin, g/dL 10.45 ± 1.71 11.07 ± 1.60 0.233
Urea, mg/dL 151.63 ± 35.78 158.33 ± 29.05 0.800
Creatinine, mg/dL 8.33 ± 2.21 8.07 ± 2.54 0.722
Albumin, mg/dL 3.50 ± 0.27 3.56 ± 0.28 0.561
Uric acid, mg/dL 6.48 ± 1.00 6.40 ± 1.18 0.818
Glucose, mg/dL 108.30 ± 40.05 126.70 ± 48.59 0.140
Ferritin, mg/dL 1,013.45 ± 410.09 802.10 ± 404.79 0.109
Total cholesterol,
mg/dL 169.09± 38.60 174.90 ± 41.88 0.638
LDL, mg/dL 98.63 ± 27.22 105.95 ± 26.86 0.387
HDL, mg/dL 34.41 ± 9.10 34.57 ± 8.71 0.953
Triglyceride, mg/dL 180.31 ± 83.28 191.66 ± 87.62 0.683
Calcium, mg/dL 9.16 ± 0.74 8.80 ± 0.60 0.887
Phosphorus, mg/dL 4.94 ± 1.29 4.71 ± 1.37 0.580
CRP, mg/dL 2.63 ± 3.70 1.64 ± 2.61 0.320
PTH, pg/mL 383.68 ± 441.61 217.95 ± 143.41 0.119
UF, mL 2,938.88 ± 675.74 2,984.21 ± 857.81 0.860
Duration of chronic 
renal failure, months 90.78 ± 67.96 74.28 ± 47.18 0.359
Kt/V 1.49 ± 0.30 1.47 ± 0.18 0.800
 Group 1: hemodialysis patients with fQRS; group 2: hemodialysis pa-
tients without fQRS; LDL, low-density lipoprotein; HDL, high-density lipo-
protein; CRP, C-reactive protein; PTH, parathyroid hormone; UF, amount 
of liquid drawn in a single dialysis session; Kt/V, product of dialyzer urea 
clearance and treatment time divided by body urea volume.
 Table 2.  Comparison of the clinical and demographic data in he-
modialysis patients
Group 1 Group 2 p 
value
Etiology of CKD, %
Diabetes mellitus 42.3 36.7 0.437
Hypertension 23.1 30.0 0.391
Glomerulonephritis 7.7 10.0 0.569
Nephrolithiasis 3.8 3.3 0.718
Unknown 22.2 17.8 0.788
Medications, %
Erythropoietin 38.5 36.7 0.94
Vitamin D 26.9 33.3 0.452
β-Blockers 11.5 20.0 0.383
ACE/ARB 0.0 3.3 0.253
Antilipidemic agent 69.2 3.3 0.536
Ca-based phosphate binders 15.5 56.7 0.245
ACE 50.0 20  0.560
Demographics
Gender male, % 42.3 53.6  0.508
Age, years 59.82 ± 13.98 66.23 ± 11.10 0.102
 Group 1: hemodialysis patients with fQRS; group 2: hemodi-
alysis patients without fQRS; CKD, chronic kidney disease; ACE, 
angiotensin-converting enzyme inhibitors; ARB, angiotensin re-
ceptor blockers.
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increase in hemodialysis patients with fQRS ( Table  3 ). 
There was a significant difference between the groups, 
and aortic elastic properties ( Table 4 ), aortic strain (5.66 
± 2.38%), and distensibility (2.63 ± 1.05 cm 2 × dyn –1 ) 
were significantly lower in the fQRS group ( p < 0.01) pa-
tients. The aortic stiffness index (9.62 ± 4.53) was signifi-
cantly higher in the fQRS group (p < 0.01).
 In this study, a statistically significant relationship was 
identified between aortic stiffness and diastolic dysfunc-
tion in hemodialysis patients (DT  r = 0.273,  p = 0.042; 
IVRT  r = 0.497,  p < 0.001; E/A ratio  r = –0.449,  p = 0.001).
 After adjusting the C-reactive protein value, disease 
duration of CKD and albumin in multiple regression 
analysis, fQRS was significantly correlated independently 
with aortic stiffness (β = 0.313,  p = 0.048; 95% confidence 
interval: 0.19–5.33). 
 Discussion 
 In this study, aortic stiffness increase and LV diastolic 
dysfunction were more common in hemodialysis patients 
with fQRS than patients without fQRS. fQRS and aortic 
stiffness were independently associated in hemodialysis 
patients. Also, it was shown that aortic stiffness increase 
was related to LV diastolic dysfunction.
 The finding that LV diastolic dysfunction was severer 
in hemodialysis patients with fQRS than patients without 
fQRS confirmed that of Ulusoy et al.  [8] who had demon-
strated that fQRS was related with systolic and diastolic 
dysfunction of the left ventricle in kidney transplant pa-
tients. Also Adar et al.  [9] showed that fQRS was indepen-
dently associated with subclinical LV dysfunction in pa-
tients with CKD and normal ejection fraction. A probable 
cause of the relationship between diastolic function and 
fQRS could be myocardial fibrosis causing inhomoge-
neous activation and fQRS formation that causes diastol-
ic dysfunction  [8–10] . 
 In this study the finding that an independent relation-
ship exists between fQRS and aortic stiffness confirmed 
that the presence of fQRS reported by Korkmaz et al.  [6] 
is associated independently with increased arterial stiff-
ness in asymptomatic hypertensive patients. However, 
Ikonomidis et al.  [11] reported the relationship between 
diastolic dysfunction and aortic distensibility in hyper-
tensive patients, and also LV mass and function were re-
ported to be related to aortic stiffness in previous studies 
 [12, 13] . There are possible explanations for the relation 
between aortic distensibility and diastolic dysfunction. 
LV diastolic dysfunction and aortic stiffness may be epi-
phenomena of the myocardial and aortic injuries in he-
modialysis patients  [14] . The second possible explanation 
is that increased aortic stiffness may also increase after-
load. An increase in afterload induces myocardial struc-
tural changes of the left ventricle and thus causes LV dia-
stolic dysfunction  [15] . Additionally, structural changes 
in left ventricle were suggested to be related with aortic 
stiffness  [15–17]. 
 Age is the main clinical marker in arterial stiffness. 
Aortic stiffness is identified to be 5–10% less in women. 
Also blood pressure and diabetes mellitus can affect aor-
 Table 3.  The measurement of echocardiographic parameters in 
groups 1 and 2
Group 1 Group 2 p value
LVEDD, mm 46.30 ± 5.76 47.30 ± 5.25 0.504
LVESD, mm 31.26 ± 6.36 32.06 ± 5.87 0.628
IVS thickness, mm 15.03 ± 10.19 112.66 ± 1.76 0.215
PW thickness, mm 12.96 ± 1.75 4,912.66 ± 1.72 0.530
LVEF, % 57.11 ± 10.75 58.13 ± 7.58 0.681
LA dimension, mm 41.88 ± 5.33 40.30 ± 5.01 0.257
Aortic diastolic
diameter, mm 30.02 ± 4.18 30.01 ± 4.59 0.998
E, m/s 58.23 ± 19.96 78.83 ± 29.74 0.004
A, m/s 77.76 ± 17.34 73.03 ± 28.38 0.463
DT, ms 237.57 ± 40.10 212.73 ± 43.73 0.030
IVRT, ms 126.84 ± 15.62 107.30 ± 17.89 0.000
Em, cm/s 5.96 ± 2.08 7.63 ± 3.06 0.023
E/A ratio 1.15 ± 0.40 0.76 ± 0.26 0.000
 Group 1: hemodialysis patients with fQRS; group 2: hemodi-
alysis patients without fQRS; LVEDD, left ventricular end-diastol-
ic dimension; LVESD, left ventricular end-systolic dimension; 
IVS, ventricular septum; PW, posterior wall; LVEF, left ventricular 
ejection fraction; LA, left atrium; E, early diastolic flow; A, atrial 
contraction signal; DT, deceleration time; IVRT, isovolumic relax-
ation time.
 Table 4.  The measurement of aortic elastic properties in groups 1 
and 2
Group 1 Group 2 p value
Aortic strain, % 5.66 ± 2.38 7.64 ± 2.84 0.007
Distensibility, cm2 × dyn–1 2.63 ± 1.05 3.58 ± 1.91 0.029
Aortic stiffness index 9.62 ± 4.53 7.02 ± 3.23 0.016
 Group 1: hemodialysis patients with fQRS; group 2: hemodi-
alysis patients without fQRS.
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tic stiffness in kidney disease  [18] . We did not observe any 
statistically significant differences between patients with 
and without fQRS in terms of age, gender, diabetes mel-
litus, blood pressure levels, chronic kidney failure dura-
tion and Kt/V value which shows adequateness of dialy-
sis. 
 Conclusion 
 In this study increased aortic stiffness and LV systolic 
dysfunction were observed more frequently in hemodi-
alysis patients with fQRS than patients without fQRS. 
fQRS was related independently with aortic stiffness. 
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